Company Filing History:
Years Active: 1987
Title: The Innovative Contributions of Irmgard Suchy
Introduction: Irmgard Suchy is a distinguished inventor based in Berlin, Germany, recognized for her innovative research and contributions to the field of geriatric medicine. With a focus on enhancing the quality of life for elderly patients, she has garnered attention for her pioneering work in pharmacology.
Latest Patents: Irmgard holds a significant patent titled "Use of Terguride as a Geriatric Agent." This patent details the application of Terguride and its physiologically compatible salts for the treatment of geriatric deficiencies. The recommended dosage ranges from 0.1 to 5.0 mg per day, showcasing its potential impact on elderly health care.
Career Highlights: Irmgard Suchy works at Schering Aktiengesellschaft, a renowned pharmaceutical company. Her career is marked by a dedication to research that contributes to the advancement of medical treatments specifically designed for the aging population. Her expertise in this specialized area has established her as a leading figure in geriatric pharmacology.
Collaborations: Throughout her career, Irmgard has collaborated with esteemed colleagues, including Bernd Aufdembrinke and Rainer Dorow. These partnerships highlight the collaborative nature of research and innovation within her field, contributing to the advancement of therapies aimed at improving geriatric health outcomes.
Conclusion: Irmgard Suchy’s work exemplifies the spirit of innovation and dedication required to address the health challenges faced by the elderly. Her patent on Terguride reflects her commitment to finding effective solutions for geriatric deficiencies. As she continues her research at Schering Aktiengesellschaft, her contributions will undoubtedly pave the way for further advancements in geriatric medicine.